EMA to probe Sputnik vaccine, Renesas Electronics, Brazil crises

The EU drug regulator will launch an investigation next week into whether clinical trials of Russia’s Sputnik V Covid-19 vaccine contravened ethical standards, and Japan’s national champion, Renesas Electronics, is being forced to diversify due to the pressures brought on by the chip industry. Plus, the FT’s Latin America editor, Michael Stott, explains how president Jair Bolsonaro lost his grip of Brazil. EU regulator to probe ethical standards of Sputnik vaccine trialshttps://www.ft.com/content/50031165-1f46-446b-be9a-36d553805fec?Chip industry pressures spur Renesas to diversifyhttps://www.ft.com/content/c583fe71-4556-4ef9-9367-a175a2033767Brazil’s coronavirus nightmare: ‘Bolsonaro is more isolated than ever’https://www.ft.com/content/55713895-2423-4259-a222-f778f9587490Nematodes the latest casualty of post-Brexit trade glitcheshttps://www.ft.com/content/888658ea-9b33-454e-bac5-c9d4a59eb201? Hosted on Acast. See acast.com/privacy for more information.

Om Podcasten

A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. Hosted on Acast. See acast.com/privacy for more information.